ROTOP CDMO Services

early stage development to commercial supply from a single source

0
Years of Know-How
0
Product approvals worldwide
0
Export countries

ROTOP is a worldwide leading company in the field of development, cGMP manufacturing, registration and commercialization of cold kits and radiopharmaceuticals for diagnostic imaging agents. Headquartered in Dresden, Germany, with more than 180 employees.

NEWS

First marketing authorization for RoTecPSMA®

We are thrilled to announce that RoTecPSMA® has been approved in the United Kingdom!

RoTecPSMA® is a technetium-99m cold kit for SPECT imaging of prostate cancer patients and the first PSMA-SPECT tracer approved in a European country. It marks a significant step forward in closing a gap in patient care, making advanced diagnostics more accessible for those affected by prostate cancer.

 

Scope of Supply and Services

  • Early Stage Development

  • cGMP Manufacturing

  • European Product Release

  • Clinical Trial Services

  • Cold Kits // Radiopharmaceuticals

  • Regulatory Consultancy

NEWS

Upcoming events

May 30 – June 02, 2026 | SNMMI Annual Meeting 

Annual Meeting Society of Nuclear Medicine and Molecular Imaging

Please contact our team to make an appointment: cdmo@rotop-pharmaka.com

NEWS

RoTecPSMA® Approved in Switzerland – Expanding Access to Advanced Prostate Cancer Diagnostics

Quality and reliability

Our products

Together with our customers and partners, we are developing cold kits and radiopharmaceuticals for the treatment of patients.

Ioflupane (123I) ROTOP

MAG-3 Kit/ NephroMAG/ Mertioscan/ IELMAG3

NanoHSA-Rotop/ Nanotop/ NanoSPECT

ROTOP-MDP

Tetrofosmin ROTOP

CAREER
job offers

We are offering numerous jobs in many different fields, from product manufacturing to administration and sales.